Corvus Pharmaceuticals
CRVS
#7815
Rank
C$0.34 B
Marketcap
$5.09
Share price
0.27%
Change (1 day)
145.77%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -C$85.27 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$37.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -C$86.33 Million130.47%
2023 -C$37.46 Million-34.57%
2022 -C$57.25 Million-4.47%
2021 -C$59.93 Million621.28%
2020 -C$8.31 Million-87.16%
2019 -C$64.68 Million-0.57%
2018 -C$65.05 Million-15.67%
2017 -C$77.14 Million53.03%
2016 -C$50.41 Million16.08%
2015 -C$43.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA